GlassScriptPhysician profile
Jeffrey John Larson
NPI 1649353947
$755,511.33
in general payments reported to CMS, 2019-2025
18 companies · $583 in 2025
The $583 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $94K · 2020: $85K · 2021: $113K · 2022: $262K · 2023: $141K · 2024: $61K · 2025: $583.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $175K · Consulting Fee: $13K · Acquisitions: $12K · Travel and Lodging: $1,279 · Food and Beverage: $630.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $175,132.62 |
| Consulting Fee | $12,750.00 |
| Acquisitions | $12,238.25 |
| Travel and Lodging | $1,279.31 |
| Food and Beverage | $629.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $424,381.20 | 2019-2025 | Tritanium |
| Depuy Synthes Products, INC. | $171,593.88 | 2022-2023 | Fibulink |
| Seaspine Orthopedics Corporation | $67,430.37 | 2019-2022 | |
| Orthofix Medical, INC. | $64,213.10 | 2023-2025 | Manta Ray, 7d Surgical System, Physio-Stim |
| Globus Medical, INC. | $16,661.30 | 2019-2023 | Reflect/Reflect Hde, Excelsiusgps Robotic Navigation System |
| Surgalign Spine Technologies, INC. | $9,855.06 | 2020-2022 | |
| Nuvasive, INC. | $331.93 | 2019 | |
| Carlsmed, INC. | $252.08 | 2022 | |
| Medtronic, INC. | $189.15 | 2022 | |
| Zimvie INC. | $153.11 | 2022-2023 | |
| Xtant Medical INC | $116.10 | 2023 | |
| Intrinsic Therapeutics | $73.46 | 2023 | Barricaid Acd (Annular Closure Device) |
| Depuy Synthes Sales INC. | $56.89 | 2019 | |
| Si-Bone, INC. | $55.51 | 2022-2023 | |
| 7d Surgical Ulc | $49.19 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $45.03 | 2022 | |
| Zimmer Biomet Holdings, INC. | $30.97 | 2020-2021 | |
| Prosidyan, INC | $23.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$187,500.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Larson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.